The SMYD3-MAP3K2 Signaling Axis Promotes Tumor Aggressiveness and Metastasis in Prostate Cancer

The authors demonstrated that SMYD3 critically regulated tumor-associated phenotypes via its methyltransferase activity in prostate cancer cells and mouse xenograft models.